Methicillin-Resistant Staphylococcus aureus central nervous system infections-Analysis and outcome

British Journal of Neurosurgery

Volumn 29, Issue 3, 2015, Pages 413-418

  Kumari, Veena H B ^a   Babu, Arun R ^a   Srinivas, Dwarakanath ^a   Siddaiah, Nagarathna ^a   Somanna, Sampath ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Infections; Meningitis; MRSA

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; LINCOMYCIN; LINEZOLID; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL MENINGITIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID DRAINAGE; CLINICAL FEATURE; COMMUNITY ACQUIRED INFECTION; DISEASE PREDISPOSITION; GLASGOW COMA SCALE; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ADOLESCENT; ADULT; AGED; CHILD; DRUG EFFECTS; FEMALE; INFANT; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; PRESCHOOL CHILD; STAPHYLOCOCCUS AUREUS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MENINGITIS, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84936929245     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2015.1006168     Document Type: Article

References (24)

1. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328 : 21-8.
2. Hussein A, Shafran S. Acute bacterial meningitis in adults. A 12-year review. Medicine (Baltimore) 2000;79: 360-8.
3. Srinivas D, Veena Kumari HB, Sampath S, Bhagavatula I, Anandappa CB. The incidence of postoperative meningitis in neurosurgery: An institutional experience. Neurol India 2011; 59 : 195-8.
4. Pintado V, Pazos R, Jim é nez-Mej í as ME, et al. Methicillin-resistant staphylococcus aureus meningitis in adults: A multicenter study of 86 cases. Medicine (Baltimore) 2012; 91 : 10-7.
5. Garner JS, Jarvis WR, Emori TG, et al. CDC defi nitions for nosocomial infections. Am J Infect Control 1988; 16 : 128-40.
6. Pintado V, Meseguer MA, Fortun J, et al. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis 2002; 21 : 864-68.
7. Rodriguez-Guardado A, Maradona JA, Perez F, et al. Postsurgery meningitis by Staphylococcus aureus: comparison between methicillin-sensitive and resistant strains. Med Clin (Barc) 2005; 124 : 102-3.
8. A guilar J, U rday-Cornejo V, D onabedian S, et al. Staphylococcus aureus meningitis. Case series and literature review. Medicine (Baltimore) 2010; 89 : 117-25.
9. Brouwer MC, Keizerweerd GD, De Gans J, Spanjaard L, Van De Beek D. Community acquired staphylococcus aureus meningitis in adults. Scand J Infect Dis 2009; 41 : 375-377.
10. Pedersen M, Benfi eld TL, Skinhoej P, et al. Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases. BMC Infect Dis 2006; 6 : 49-53.
11. S afdar N, M aki D G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium diffi cile, and Candida. Ann Intern Med 2002; 136: 834-44.
12. Gordon JJ, Harter DH, Phair JP. Meningitis due to Staphylococcus aureus. Am J Med 1985; 78 : 965-70.
13. Kim JH, Van der Horst C, Mulrow CD, Corey GR. Staphylococcus aureus meningitis: review of 28 cases. Rev Infect Dis 1989; 11 : 698-706.
14. Arda B, Yamazhan T, Sipahi OR, et al. M eningitis due to methicillinresistant Staphylococcus aureus (MRSA): A review of 10 cases. Int J Antimicrobial Agents 2005; 25 : 414-8.
15. Chang WN, Lu CH, Wu JJ, et al. Staphylococcus aureus meningitis in adults: A clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection 2001; 29 : 245-250.
16. Liu C, Bayer A, Cosgrove SE, et al. C linical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011; 52 : e18-55.
17. N aesens R, R onsyn M, D ruwe P, et al. Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus. J Med Microbiol 2009; 58 : 1247-51.
18. Kessler AT, Kourtis AP. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid. Infection 2007; 35 : 271-4.
19. Sipahi OR, Bardak RS, Turhan T, et al. Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: A series of 17 cases. Scand J Infect Dis 2011; 43 : 757-64.
20. Calik S, Turhan T, Yurtseven T, Sipahi OR, Buke C. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model. Med Sci Monit 2012; 18 : SC5-8.
21. Wallace MR, Sander AW, Licitra C, et al. Methicillin-resistant Staphylococcus aureus meningitis successfully treated with daptomycin. Infect Dis Clin Pract 2009; 17 : 69-70.
22. Le J, Bookstaver PB, Rudisill CN, et al. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: highdose and combination daptomycin therapy. Ann Pharmacother 2010; 44 : 2001-6.
23. Fong IW, Ranalli P. Staphylococcus aureus meningitis. Q J Med 1984; 53 : 289-99.
24. Lerche A, Rasmussen N, Wandall JH, Bohr VA. Staphylococcus aureus meningitis: A review of 28 consecutive communityacquired cases. Scand J Infect Dis 1995; 27 : 569-73.